This early-stage candidate is being evaluated for the treatment of oHCM and has demonstrated ... unaddressed medical needs in the treatment of HCM. In other recent news, Cytokinetics has reported ...
H.C. Wainwright's reiteration of the Buy rating and the $90 price target for Cytokinetics reflects confidence in the clinical advancement of EDG-7500 and its potential to meet the unaddressed medical ...